Jeffrey Garavaglia, Anthony DeBastiani, Jessica Peaslee, Nicholas Brandmeir
{"title":"Chemical Stability Testing of Solutions for Intraventricular Irrigations via IRRA<i>flow</i> Ventricular Drain System.","authors":"Jeffrey Garavaglia, Anthony DeBastiani, Jessica Peaslee, Nicholas Brandmeir","doi":"10.1177/00185787251337611","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> Advances have been made with delivery of medications via continuous intrathecal irrigating ventricular drains such as IRRAflow (IRRAS). Medications including vancomycin, tobramycin, daptomycin and nicardipine are currently being used as ventricular irrigations via the IRRAflow device. The purpose of this study was to evaluate the chemical stability of minute concentrations of daptomycin, nicardipine, tobramycin, and vancomycin for administration via IRRAflow intrathecal catheters. <b>Methods:</b> Commercially available formulations of daptomycin, nicardipine, tobramycin, and vancomycin were each diluted in separate normal saline (NS) 1000 mL bags to final concentrations of daptomycin 2 mg/1000 mL NS, nicardipine 2.5 mg/1000 mL NS, tobramycin 4 mg/1000 mL NS, and vancomycin 4 mg/1000 mL NS. Samples from each compound were transferred into 2.5 mL glass vials and evaluated in triplicate fashion using ultra-performance liquid chromatography and tandem mass spectrometry (LC-MS/MS). Each injection was analyzed in comparison to its respective calibration curve and a mean result for each time point was determined. The concentration of the samples was tested at 0, 6 and 12-hours for vancomycin, daptomycin, and tobramycin and 0, 4 and 8-hours for nicardipine. All irrigations were kept at room temperature and were not protected from light. <b>Results:</b> All samples tested were found to be chemically stable at various testing time points. Daptomycin retained a mean of 94.3% of initial concentration at 12 hours while tobramycin retained 93.1% of its initial concentration at 12 hours. Vancomycin samples were found to be 92.9% of initial concentration at 12 hours and nicardipine maintained a mean of 90.6% of initial concentration at 8 hours. Future studies could assess these conditions to potentially further stability data. <b>Conclusion:</b> With use of LC-MS, we demonstrated that dilute concentrations of vancomycin, daptomycin, and tobramycin maintain at least 90% of initial concentration for 12 hours at room temperature, whereas nicardipine remained chemically stable for 8 hours at room temperature.</p>","PeriodicalId":13002,"journal":{"name":"Hospital Pharmacy","volume":" ","pages":"00185787251337611"},"PeriodicalIF":0.8000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181189/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00185787251337611","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Advances have been made with delivery of medications via continuous intrathecal irrigating ventricular drains such as IRRAflow (IRRAS). Medications including vancomycin, tobramycin, daptomycin and nicardipine are currently being used as ventricular irrigations via the IRRAflow device. The purpose of this study was to evaluate the chemical stability of minute concentrations of daptomycin, nicardipine, tobramycin, and vancomycin for administration via IRRAflow intrathecal catheters. Methods: Commercially available formulations of daptomycin, nicardipine, tobramycin, and vancomycin were each diluted in separate normal saline (NS) 1000 mL bags to final concentrations of daptomycin 2 mg/1000 mL NS, nicardipine 2.5 mg/1000 mL NS, tobramycin 4 mg/1000 mL NS, and vancomycin 4 mg/1000 mL NS. Samples from each compound were transferred into 2.5 mL glass vials and evaluated in triplicate fashion using ultra-performance liquid chromatography and tandem mass spectrometry (LC-MS/MS). Each injection was analyzed in comparison to its respective calibration curve and a mean result for each time point was determined. The concentration of the samples was tested at 0, 6 and 12-hours for vancomycin, daptomycin, and tobramycin and 0, 4 and 8-hours for nicardipine. All irrigations were kept at room temperature and were not protected from light. Results: All samples tested were found to be chemically stable at various testing time points. Daptomycin retained a mean of 94.3% of initial concentration at 12 hours while tobramycin retained 93.1% of its initial concentration at 12 hours. Vancomycin samples were found to be 92.9% of initial concentration at 12 hours and nicardipine maintained a mean of 90.6% of initial concentration at 8 hours. Future studies could assess these conditions to potentially further stability data. Conclusion: With use of LC-MS, we demonstrated that dilute concentrations of vancomycin, daptomycin, and tobramycin maintain at least 90% of initial concentration for 12 hours at room temperature, whereas nicardipine remained chemically stable for 8 hours at room temperature.
目的:通过连续鞘内冲洗脑室引流如IRRAflow (IRRAS)给药已取得进展。包括万古霉素、妥布霉素、达托霉素和尼卡地平在内的药物目前通过irrflow装置用于心室冲洗。本研究的目的是评估小浓度的达托霉素、尼卡地平、妥布霉素和万古霉素通过IRRAflow鞘内导管给药的化学稳定性。方法:将市售的达托霉素、尼卡地平、妥布霉素和万古霉素分别在生理盐水(NS) 1000 mL袋中稀释至最终浓度:达托霉素2 mg/1000 mL NS、尼卡地平2.5 mg/1000 mL NS、妥布霉素4 mg/1000 mL NS、万古霉素4 mg/1000 mL NS。将每种化合物的样品转移到2.5 mL的玻璃瓶中,使用超高效液相色谱和串联质谱(LC-MS/MS)进行三次重复评估。将每次注射与各自的校准曲线进行对比分析,并确定每个时间点的平均结果。在0、6和12小时检测万古霉素、达托霉素和妥布霉素的浓度,在0、4和8小时检测尼卡地平的浓度。所有的灌溉都保存在室温下,没有遮光保护。结果:所有测试样品在不同的测试时间点都是化学稳定的。达托霉素在12小时的平均浓度为初始浓度的94.3%,妥布霉素在12小时的平均浓度为初始浓度的93.1%。万古霉素在12小时的浓度为初始浓度的92.9%,尼卡地平在8小时的浓度维持在初始浓度的90.6%。未来的研究可以评估这些条件,以获得进一步的稳定性数据。结论:利用LC-MS,我们证明了万古霉素、达托霉素和妥布霉素的稀释浓度在室温下保持至少90%的初始浓度12小时,而尼卡地平在室温下保持化学稳定8小时。
期刊介绍:
Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.